• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Episodic drug treatment in the management of paroxysmal arrhythmias.

作者信息

Margolis B, DeSilva R A, Lown B

出版信息

Am J Cardiol. 1980 Mar;45(3):621-6. doi: 10.1016/s0002-9149(80)80014-2.

DOI:10.1016/s0002-9149(80)80014-2
PMID:7355758
Abstract

The use of maintenance medication in the treatment of episodic cardiac arrhythmia is often complicated by problems of patient compliance with therapy and adverse side effects. Furthermore, repeated hospitalizations and cardioversions are both costly and inconvenient. A method of intermittent drug therapy is described in which antiarrhythmic medication is taken only at the onset of an episode of arrhythmia. This approach was effective in terminating both supraventricular and ventricular arrhythmias in 24 of 32 patients and obviated the need for hospitalization and further treatment. In cases in which maintenance therapy was required because of the frequent occurrence of arrhythmia, periodic drug therapy was still of value in the treatment of breakthrough episodes. The use of intermittent drug therapy is a safe and effective approach to the management of episodic cardiac arrhythmia and, in addition, results in significant financial saving.

摘要

相似文献

1
Episodic drug treatment in the management of paroxysmal arrhythmias.
Am J Cardiol. 1980 Mar;45(3):621-6. doi: 10.1016/s0002-9149(80)80014-2.
2
Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.醋酸氟卡尼在室上性快速心律失常患者常规护理中的安全性和实用性:一项多中心试验的结果。氟卡尼室上性心动过速研究组
Am J Cardiol. 1996 Jan 25;77(3):72A-82A. doi: 10.1016/s0002-9149(97)89121-7.
3
Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter.新型选择性Ⅲ类抗心律失常药物多非利特对阵发性心房颤动或心房扑动的疗效及安全性
Am J Cardiol. 1992 Feb 1;69(4):417-9. doi: 10.1016/0002-9149(92)90247-v.
4
[Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].症状性阵发性心房颤动/心房扑动发作的药物预防。SOPAT研究的目标与设计。代表试验医师的研究者执行委员会
Z Kardiol. 1999 Mar;88(3):185-94. doi: 10.1007/s003920050275.
5
[Drug therapy of cardiac arrhythmias 199].[心律失常的药物治疗 199]
Fortschr Med. 1997 Nov 30;115(33):32, 34-6, 38.
6
Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.氟卡尼与普罗帕酮用于有症状阵发性室上性快速心律失常长期管理的安全性。来自氟卡尼和普罗帕酮意大利研究(FAPIS)组的报告。
Eur Heart J. 1995 Dec;16(12):1943-51. doi: 10.1093/oxfordjournals.eurheartj.a060852.
7
[The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].[对有发生抗心律失常治疗并发症高风险的缺血性心脏病患者阵发性室上性心律失常的治疗]
Ter Arkh. 1996;68(5):57-60.
8
[Drug prevention of recurrence in paroxysmal and chronic atrial fibrillation].[药物预防阵发性和慢性心房颤动复发]
Z Kardiol. 1994;83 Suppl 5:87-96.
9
Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.普罗帕酮治疗房性快速性心律失常的安慰剂对照评估。
Am J Cardiol. 1998 Oct 16;82(8A):59N-65N. doi: 10.1016/s0002-9149(98)00739-5.
10
[Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].维拉帕米/奎尼丁对阵发性及持续性心房颤动或心房扑动的转复率及复发预防
Med Klin (Munich). 1996 Oct 15;91(10):617-25.

引用本文的文献

1
Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation.阵发性心房颤动发作患者中两种口服剂型氟卡尼的吸收动力学和药效学
Eur J Clin Pharmacol. 2004 Dec;60(10):693-701. doi: 10.1007/s00228-004-0831-3. Epub 2004 Nov 16.
2
Absorption kinetics of oral sotalol combined with cisapride and sublingual sotalol in healthy subjects.健康受试者口服索他洛尔联合西沙必利及舌下含服索他洛尔的吸收动力学
Br J Clin Pharmacol. 1998 May;45(5):485-90. doi: 10.1046/j.1365-2125.1998.00706.x.
3
Absorption kinetics of oral and rectal flecainide in healthy subjects.
健康受试者口服和直肠给予氟卡尼的吸收动力学
Eur J Clin Pharmacol. 1990;38(6):595-8. doi: 10.1007/BF00278588.